<?xml version='1.0' encoding='utf-8'?>
<document id="24975211"><sentence text="Liquid chromatography-mass spectrometry analysis of diethylcarbamazine in human plasma for clinical pharmacokinetic studies."><entity charOffset="52-70" id="DDI-PubMed.24975211.s1.e0" text="diethylcarbamazine" /></sentence><sentence text="A sensitive and selective liquid chromatographic method using mass spectrometric detection was developed for the determination of diethylcarbamazine (DEC) in human plasma"><entity charOffset="130-148" id="DDI-PubMed.24975211.s2.e0" text="diethylcarbamazine" /><entity charOffset="150-153" id="DDI-PubMed.24975211.s2.e1" text="DEC" /><pair ddi="false" e1="DDI-PubMed.24975211.s2.e0" e2="DDI-PubMed.24975211.s2.e0" /><pair ddi="false" e1="DDI-PubMed.24975211.s2.e0" e2="DDI-PubMed.24975211.s2.e1" /></sentence><sentence text=" DEC and its stable isotope internal standard d3-DEC were extracted from 0"><entity charOffset="1-3" id="DDI-PubMed.24975211.s3.e0" text="DEC" /><entity charOffset="49-51" id="DDI-PubMed.24975211.s3.e1" text="DEC" /><pair ddi="false" e1="DDI-PubMed.24975211.s3.e0" e2="DDI-PubMed.24975211.s3.e0" /><pair ddi="false" e1="DDI-PubMed.24975211.s3.e0" e2="DDI-PubMed.24975211.s3.e1" /></sentence><sentence text="25mL of human plasma using solid phase extraction" /><sentence text=" Chromatography was performed using a Phenomenex Synergi 4μ Fusion-RP column (2mm×250mm) with gradient elution" /><sentence text=" The retention time was approximately 4" /><sentence text="8min" /><sentence text=" The assay was linear from 4 to 2200ng/mL" /><sentence text=" Analysis of quality control samples at 12, 300, and 1700ng/mL (N=15) had interday coefficients of variation of 8" /><sentence text="4%, 5" /><sentence text="4%, and 6" /><sentence text="2%, respectively (N=15)" /><sentence text=" Interday bias results were -2" /><sentence text="2%, 6" /><sentence text="0%, and 0" /><sentence text="8%, respectively" /><sentence text=" Recovery of DEC from plasma ranged from 84"><entity charOffset="13-15" id="DDI-PubMed.24975211.s17.e0" text="DEC" /></sentence><sentence text="2% to 90" /><sentence text="1%" /><sentence text=" The method was successfully applied to clinical samples from patients with lymphatic filariasis from a drug-drug interaction study between DEC and albendazole and/or ivermectin"><entity charOffset="148-159" id="DDI-PubMed.24975211.s20.e0" text="albendazole" /><entity charOffset="167-177" id="DDI-PubMed.24975211.s20.e1" text="ivermectin" /><entity charOffset="140-149" id="DDI-PubMed.24975211.s20.e2" text="DEC" /><pair ddi="false" e1="DDI-PubMed.24975211.s20.e2" e2="DDI-PubMed.24975211.s20.e2" /><pair ddi="false" e1="DDI-PubMed.24975211.s20.e2" e2="DDI-PubMed.24975211.s20.e0" /><pair ddi="false" e1="DDI-PubMed.24975211.s20.e2" e2="DDI-PubMed.24975211.s20.e1" /><pair ddi="false" e1="DDI-PubMed.24975211.s20.e0" e2="DDI-PubMed.24975211.s20.e0" /><pair ddi="false" e1="DDI-PubMed.24975211.s20.e0" e2="DDI-PubMed.24975211.s20.e1" /></sentence><sentence text=" " /></document>